Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS
· Real-Time Price · USD
7.85
-0.13 (-1.63%)
At close: May 01, 2025, 3:59 PM
Regulus Therapeutics Revenue
Regulus Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, Regulus Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
34
Market Cap
520.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | n/a |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | -100.00% |
| Dec 31, 2020 | 10.01M | n/a |